Inhibition of RANK signaling pathway could be potential new therapy in breast cancer

[News]

Researchers at the Institute of Biomedical Research of Bellvitge, led by Dr. Eva Gonzalez-Suarez, have shown that pharmacological and genetic inhibition of signaling pathway RANK / RANKL leads to a significant reduction in recurrences and metastases in breast cancer in a mouse animal model.

More... (http://www.news-medical.net/news/20160913/Inhibition-of-RANK-signaling-pathway-could-be-potential-new-therapy-in-breast-cancer.aspx)